Bishal Gyawali/scri.queensu.ca
Jun 2, 2025, 07:40
Bishal Gyawali: The most practice changing trial from ASCO 2025 is now live
Bishal Gyawali, Associate Professor at Queen’s University, shared on X:
“The most practice changing trial from ASCO 2025 is now live on NEJM. If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival.
Perfect case example of a cancer ground shot trial.”
Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head Urologic Oncology at Aura Biosciences, shared Bishal Gyawali’s post, and added:
“So important! Another call to integrate structured physical exercise in cancer care as a standard of care.
Much more than improving QoL
Improving oncological outcomes.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 00:35
Jun 3, 2025, 16:39